{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T00:05:59Z","timestamp":1759017959038,"version":"3.44.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.annder.2017.07.004","type":"journal-article","created":{"date-parts":[[2017,9,13]],"date-time":"2017-09-13T20:01:09Z","timestamp":1505332869000},"page":"104-108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Aggravation apparente d\u2019un psoriasis r\u00e9v\u00e9lant un surdosage en m\u00e9thotrexate"],"prefix":"10.1016","volume":"145","author":[{"given":"R.","family":"Haber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Baroudjian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Battistella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Bagot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Petit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2017.07.004_bib0005","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1529-8019.2007.00135.x","article-title":"Methotrexate in dermatology","volume":"20","author":"Bangert","year":"2007","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.annder.2017.07.004_bib0010","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.jaad.2008.11.906","article-title":"Methotrexate and psoriasis: 2009\u00a0National Psoriasis Foundation Consensus Conference","volume":"60","author":"Kalb","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2017.07.004_bib0015","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2310\/7750.2011.10078","article-title":"Methotrexate-induced cutaneous ulcers in a nonpsoriatic patient: case report and review of the literature","volume":"15","author":"Kurian","year":"2011","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.annder.2017.07.004_bib0020","first-page":"946716","article-title":"Acute methotrexate toxicity: fatal condition in two cases of psoriasis","volume":"2014","author":"Jariwala","year":"2014","journal-title":"Case Rep Dermatol Med"},{"key":"10.1016\/j.annder.2017.07.004_bib0025","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1365-2141.2009.07765.x","article-title":"Advances in individual prediction of methotrexate toxicity: a review","volume":"146","author":"Schmiegelow","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.annder.2017.07.004_bib0030","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.autrev.2014.08.027","article-title":"Clinical characteristics and risk factors for low-dose methotrexate toxicity: a cohort of 28\u00a0patients","volume":"13","author":"Kivity","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.annder.2017.07.004_bib0035","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00280-016-3043-5","article-title":"Methotrexate-induced toxicity pharmacogenetics: an umbrella review of systematic reviews and meta-analyses","volume":"78","author":"Campbell","year":"2016","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.annder.2017.07.004_bib0040","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/art.21573","article-title":"Risk genotypes in folate-dependent enzymes and their association with methotrexate-related side effects in rheumatoid arthritis","volume":"5","author":"Weisman","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.annder.2017.07.004_bib0045","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1046\/j.1468-3083.2000.00058.x","article-title":"Methotrexate in psoriasis: 26\u00a0years\u2019 experience with low-dose long-term treatment","volume":"14","author":"Haustein","year":"2000","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2017.07.004_bib0050","doi-asserted-by":"crossref","first-page":"410","DOI":"10.4103\/0253-7613.115001","article-title":"Inflamed psoriatic plaques: drug toxicity or disease exacerbation?","volume":"45","author":"Jindal","year":"2013","journal-title":"Indian J Pharmacol"},{"key":"10.1016\/j.annder.2017.07.004_bib0055","first-page":"527","article-title":"Intoxication aigue au m\u00e9thotrexate\u00a0: \u00e0 propos de 16\u00a0cas rapport\u00e9s au centre anti-poisons de Paris et revue de la litt\u00e9rature","volume":"51","author":"Maignen","year":"1996","journal-title":"Therapie"},{"key":"10.1016\/j.annder.2017.07.004_bib0060","first-page":"168","article-title":"Methotrexate-induced toxic epidermal necrolysis-like skin toxicity","volume":"17","author":"Gaigl","year":"2007","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.annder.2017.07.004_bib0065","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jaad.2015.06.015","article-title":"Low-dose methotrexate induced skin toxicity: keratinocyte dystrophy as a histologic marker","volume":"73","author":"Delyon","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2017.07.004_bib0070","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/s004030050369","article-title":"Reduced folate carrier (RFC-1) gene expression in normal and psoriatic skin","volume":"290","author":"Sprecher","year":"1998","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.annder.2017.07.004_bib0075","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.2147\/TCRM.S1155","article-title":"Methotrexate-induced cutaneous ulceration in patients with erythrodermic mycosis fungoides","volume":"4","author":"Breneman","year":"2008","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.annder.2017.07.004_bib0080","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0190-9622(96)90097-3","article-title":"Erosion of psoriatic plaques: an early sign of methotrexate toxicity","volume":"35","author":"Pearce","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2017.07.004_bib0085","doi-asserted-by":"crossref","first-page":"7","DOI":"10.5070\/D3207023133","article-title":"Cutaneous erosions: a herald for impending pancytopenia in methotrexate toxicity","volume":"20","author":"Shiver","year":"2014","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.annder.2017.07.004_bib0090","doi-asserted-by":"crossref","first-page":"2","DOI":"10.5070\/D381Q6R16G","article-title":"Acute methotrexate toxicity seen as plaque psoriasis ulceration and necrosis: a diagnostic clue","volume":"17","author":"Fridlington","year":"2011","journal-title":"Dermatol Online J"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963817303083?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963817303083?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T11:05:36Z","timestamp":1758971136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963817303083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0151963817303083"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2017.07.004","relation":{},"ISSN":["0151-9638"],"issn-type":[{"type":"print","value":"0151-9638"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aggravation apparente d\u2019un psoriasis r\u00e9v\u00e9lant un surdosage en m\u00e9thotrexate","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2017.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}